On Tuesday, Missouri’s defense of its ban on gender-affirming care for minors faced a significant challenge as its expert witness, John Michael Bailey, came under intense scrutiny during cross-examination. The trial centers on a 2023 law that prohibits puberty blockers and hormone therapy for minors, and the outcome could impact the future of transgender health care in the state.